These Analysts Revise Their Forecasts On UiPath Following Q2 Results
UiPath met Q2 EPS estimates, beat revenue forecasts and raised FY27 guidance, but shares fell 12.4% as analysts downgraded or held ratings.
UiPath did really well—they made the money people expected and even made more from sales. But some money experts said to be careful anyway, so the stock price went down. When experts disagree with good news, it's worth watching to understand what they're worried about.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.